People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

The study highlights how color vision deficiency can delay bladder cancer diagnosis, increasing mortality risk and ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in reproductive health, urology and gastroenterology, to evaluate a new ...

ImmunityBio Inc. (NASDAQ:IBRX) shares climbed nearly 20% in premarket trading on Tuesday after the company said it held positive discussions with the U.S. Food and Drug Administration regarding its ...

When Lisa Dutton was declared free of breast cancer in 2017, she took a moment to celebrate with family and friends, even though she knew her cancer journey might not be over. As many as one-third of ...

UPDATE 1/8/26 at 11:51 a.m. ET — Pat Finn’s cause of death has been confirmed. TMZ obtained Finn’s death certificate on Wednesday, January 7, revealing he died from a malignant tumor in his bladder.

A study published by the Asian Journal of Urology reports that certain marijuana-derived extracts including CBC and THC may have meaningful anti-cancer effects against bladder cancer cells, including ...